Read the latest positive news, breakthroughs, and inspiring stories about penn medicine, curated daily by BrightWire.
A generous $25 million donation is powering Penn Medicine's bold new push to find cures for heart disease, the leading cause of death in America. The gift will fund groundbreaking research that could save millions of lives.
Doctors at Penn Medicine are testing a revolutionary cancer treatment that zaps tumors in less than a second instead of months. The FLASH proton therapy could transform how we fight cancer with fewer side effects and faster recovery.
Scientists at Penn received $10 million to develop the first treatment for RVCL, a deadly genetic disease affecting fewer than 50 families worldwide. The new drug could prevent symptoms in people like Lindsay Ward, who's watching her mother lose her vision and mobility to the same disease she inherited.
Scientists at Penn Medicine discovered that a chromosome-protecting protein also helps muscle stem cells maintain their ability to repair damaged tissue. Without this protein, injured muscles turn to fat and scar tissue instead of healing.
An investigational therapy for multiple myeloma shrank tumors in over 40% of heavily pre-treated patients, offering hope through a completely new treatment pathway. Even better, patients get a break after one year instead of lifelong infusions.
Dr. David Fajgenbaum received last rites in his twenties, then found his own cure by repurposing an existing drug. Now his nonprofit uses AI to match 4,000 drugs against 18,000 diseases, hunting for overlooked treatments hiding in plain sight.
A revolutionary cancer treatment just gave a Philadelphia man his third kidney transplant by removing the antibodies that kept rejecting donors. Penn Medicine's breakthrough trial could open transplants to thousands of patients currently deemed "impossible to match."
Nine patients with aggressive cancers are responding to a groundbreaking cell therapy that works like an on-off switch, avoiding the exhaustion problem that has limited cancer treatments. The therapy showed zero serious side effects and actual tumor shrinkage in patients who had already tried four other treatments.
At 32, Yentli Soto Albrecht has a 95% chance of developing the same fatal disease that killed her father. She's managing 11 research projects to find a cure in time.
A medical student who inherited the genetic mutation that killed her father is now leading eleven research projects to cure ALS before it affects her. Yentli Soto Albrecht has a 95% chance of developing the fatal disease, but she's turning her fate into fuel for breakthrough research.
Scientists have developed the first brain-targeted gene therapy that stops chronic pain without addiction risk, offering hope to 50 million Americans. Early tests show it works like morphine but skips the dangerous side effects that fuel the opioid crisis.
A new University of Pennsylvania study reveals telemedicine appointments cost five times less than in-person visits for common conditions, with patients needing fewer follow-ups. This isn't just about convenience anymore—it's about making healthcare more affordable and accessible for everyone.